BIOLASE to Host Second Quarter 2013 Results Conference Call and Webcast on August 7th at 4:30 p.m. EDT IRVINE, CA -- (Marketwired) -- 07/25/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, and a pioneer in laser surgery in other medical specialties, announced today that the Company will host a conference call on Wednesday, August 7th, at 4:30 p.m. Eastern Daylight Time to discuss its operating results for the second quarter ended June 30, 2013, and to answer questions. The Company's full financial results release will be distributed prior to the conference call, at approximately 4:05 p.m. EDT that same day. Phone Participation To listen to the conference call live via telephone, please dial 1-877-407-4019 from the U.S. or, for international callers, please dial 1-201-689-8337, approximately 10 minutes before the start time. Webcast Participation To listen to the conference call live via the Internet, visit the Investors section of the BIOLASE(R) website at www.biolase.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software. Replay An audio archive of the webcast will be available for ninety days on the Investors section of the BIOLASE website. About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's proprietary laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaginative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers. Other laser products under development address ophthalmology and other medical and consumer markets. For updates and information on WaterLase(R) and laser dentistry, find BIOLASE online at www.biolase.com, Facebook, Twitter, Pinterest, LinkedIn, Instagram and YouTube. BIOLASE(R) and WaterLase(R) are registered trademarks of BIOLASE, Inc. For further information, please contact: Michael Porter Porter, LeVay & Rose, Inc. 212-564-4700
BIOLASE to Host Second Quarter 2013 Results Conference Call and Webcast on August 7th at 4:30 p.m. EDT
Press spacebar to pause and continue. Press esc to stop.